Equities

InnovAge Holding Corp

INNV:NSQ

InnovAge Holding Corp

Actions
Health CareHealth Care Providers
  • Price (USD)6.10
  • Today's Change0.11 / 1.84%
  • Shares traded53.21k
  • 1 Year change-13.11%
  • Beta0.3915
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year InnovAge Holding Corp grew revenues 11.01% from 688.09m to 763.86m. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -40.67m to -21.34m.
Gross margin17.29%
Net profit margin-3.04%
Operating margin-3.03%
Return on assets-4.17%
Return on equity-7.55%
Return on investment-5.96%
More ▼

Cash flow in USDView more

In 2024, cash reserves at InnovAge Holding Corp fell by 70.31m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 36.90m for operations while cash used for investing totalled 26.37m.
Cash flow per share-0.0303
Price/Cash flow per share--
Book value per share1.98
Tangible book value per share0.9167
More ▼

Balance sheet in USDView more

InnovAge Holding Corp has a Debt to Total Capital ratio of 21.60%, a lower figure than the previous year's 26.31%.
Current ratio1.25
Quick ratio--
Total debt/total equity0.3068
Total debt/total capital0.216
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 47.66%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
47.64
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.